| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $127,100 | +2,000 | +5.4% | $63.55 | 39,217 | 01 Dec 2021 | Direct | |
| transaction | XYL | Common Stock | Sale | $242,647 | -2,000 | -5.1% | $121.32 | 37,217 | 01 Dec 2021 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -2,000 | -4.7% | $0.000000 | 40,423 | 01 Dec 2021 | Common | 2,000 | $63.55 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. |
| F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 441 Shares were sold at a range of prices from $118.56 to $119.23. 200 Shares were sold at a range of prices from $119.66 to $120.37. 400 Shares were sold at a range of prices from $120.94 to $121.61. 601 Shares were sold at a range of prices from $121.94 to $122.79. 358 Shares were sold at a range of prices from $122.97 to $123.27. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| F3 | The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023. |